Paul F. Truex
2015
In 2015, Paul F. Truex earned a total compensation of $3.2M as Former CEO and Director at Anthera Pharmaceuticals, a 135% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $235,125 |
|---|---|
| Option Awards | $2,536,275 |
| Salary | $466,250 |
| Total | $3,237,650 |
Truex received $2.5M in option awards, accounting for 78% of the total pay in 2015.
Truex also received $235.1K in non-equity incentive plan and $466.3K in salary.
Rankings
In 2015, Paul F. Truex's compensation ranked 2,881st out of 13,638 executives tracked by ExecPay. In other words, Truex earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,881 out of 13,638 | 79th |
Division Manufacturing | 1,020 out of 5,187 | 80th |
Major group Chemicals And Allied Products | 378 out of 1,857 | 80th |
Industry group Drugs | 295 out of 1,531 | 81st |
Industry Pharmaceutical Preparations | 234 out of 1,179 | 80th |
Source: SEC filing on March 16, 2017.
Truex's colleagues
We found three more compensation records of executives who worked with Paul F. Truex at Anthera Pharmaceuticals in 2015.